These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 376947)

  • 1. Current research review. Surgery and fibrinolysis.
    Risberg B
    J Surg Res; 1979 Jun; 26(6):698-715. PubMed ID: 376947
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent progress in fibrinolysis.
    Mannucci PM; Minetti D; Mari D
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):328-35. PubMed ID: 160079
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulation and fibrinolytic studies following use of proteinase inhibitors in prostatic surgery.
    Phillips LL; Weiss R; Wolf C
    Ann N Y Acad Sci; 1968 Jun; 146(2):737-44. PubMed ID: 4239442
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver transplantation in man--IV, Haemorrhage and thrombosis.
    Flute PT; Rake MO; Williams R; Seaman MJ; Calne RY
    Br Med J; 1969 Jul; 3(5661):20-3. PubMed ID: 4892036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Determination of the components of fibrinolytic system].
    Slobozhankina IK
    Lab Delo; 1973; 11():662-4. PubMed ID: 4132568
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the role of basophilic leukocytes and mast cells in fibrinolysis and allergy. I. Effect of fibrinolytic and antifibrinolytic agents on the degranulation degree of basophilic leukocytes].
    Frick G; Frick U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):389-403. PubMed ID: 4168276
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinolytic hemorrhage in surgery and its treatment with p-aminomethylbenzoic acid].
    Hellinger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 87(1):32-40. PubMed ID: 4173878
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surgical hemorrhagic syndrome. Elaboration of a practical procedure of investigation and treatment in the absence of a specialized laboratory].
    Otteni JC; Boyer C; Girardel JM; Gauthier-Lafaye JP
    Anesth Analg (Paris); 1969; 26(1):89-106. PubMed ID: 5793321
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Nov; 108(11):655-75 contd. PubMed ID: 5378688
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 12. [Local fibroinolytic hemorrhages in orthopedic operations].
    Sturm G
    Beitr Orthop Traumatol; 1968 Aug; 15(8):437-44. PubMed ID: 5733027
    [No Abstract]   [Full Text] [Related]  

  • 13. Surgical bleeding.
    Bachmann F; Pichairut O
    Med Clin North Am; 1972 Jan; 56(1):207-19. PubMed ID: 4550189
    [No Abstract]   [Full Text] [Related]  

  • 14. Antifibrinolytic drugs in the treatment of urinary tract haemorrhage.
    Andersson L
    Prog Surg; 1972; 10():76-93. PubMed ID: 4670671
    [No Abstract]   [Full Text] [Related]  

  • 15. Empiric use of anticoagulant and fibrinolytic agents in surgery.
    Laufman H
    Thromb Diath Haemorrh Suppl; 1973; 56():265-73. PubMed ID: 4549137
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 17. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thromboembolic complications, the coagulation and fibrinolytic blood system in heart defects with pronounced circulatory insufficiency].
    Gritsiuk AI
    Kardiologiia; 1969 Sep; 9(9):21-8. PubMed ID: 4244024
    [No Abstract]   [Full Text] [Related]  

  • 19. POSTOPERATIVE CHANGES IN THE COAGULATION FACTORS AND THE FIBRINOLYTIC SYSTEM.
    OLOW B
    Scand J Clin Lab Invest; 1964; 16():SUPPL 78:30-3. PubMed ID: 14199706
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of urokinase and tissue activator in sustaining bleeding and the management thereof with EACA and AMCA.
    Andersson L; Nilsoon IM; Colleen S; Granstrand B; Melander B
    Ann N Y Acad Sci; 1968 Jun; 146(2):642-58. PubMed ID: 5254275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.